TLR4 and neoplasm: The present study revealed that the active ingredients of YFBP, such as LUT, SIT, MYA, and VAN, might exert anti-tumor effects by downregulating SMOX expression through anti-inflammatory effects and the regulation of the TLR4/NF-κB signaling pathway.